Frontier Science Scotland Strengthens Board of Trustees with New Appointment
2024年6月17日 - 5:00PM
Frontier Science Scotland (FSS), a leading contract clinical
research organisation, advancing drug development by delivering
excellence in clinical trials, announces the appointment of
Professor Bjoern Schelter as a new Director to its Board of
Trustees. Bjoern brings valuable strategic insights into the
Company’s core capabilities across clinical trials including data
management, biostatistical analysis and quality assurance.
Professor Bjoern Schelter is CEO of GT Diagnostics (UK) Ltd and
Chief Analytics Officer of TauRx Therapeutics and is also
affiliated with the University of Aberdeen as Professor for Applied
Mathematics. With over 20 years’ experience in the health care
sector, Bjoern has led research teams since 2006. The focus
of his work is on developing data-science based technologies
to advance the understanding of diseases and ultimately help
patients around the world.
Professor Chris Robertson, of the Department of Mathematics and
Statistics at the University of Strathclyde, Glasgow, and Chair of
FSS’s Board of Trustees, added, “I am delighted to welcome
Bjoern to the FSS Board of Trustees. His extensive leadership
experience in healthcare R&D, specifically in data-science
based technologies and quality assurance in clinical trials, will
be a source invaluable advice as FSS expands its service offering
to global industry partners.”
Professor Bjoern Schelter commented on his appointment, “I
am deeply interested in FSS and its outstanding services through a
not-for-profit model. Therefore I am pleased to be part of the FSS
Board. I look forward to assisting FSS to develop its services and
grow as an organisation.”
About Frontier Science
Scotland
Frontier Science Scotland (FSS) is a leading clinical data
research organisation, advancing drug development by delivering
excellence in clinical trials to its customers. We provide
biostatistic, data management and quality assurance services to
global commercial and academic partners covering all aspects of the
design, conduct and analysis of clinical trials.
FSS has an extensive track record as a dependable partner
providing specific expertise to support major international Phase
II and III clinical trials in oncology, neurology (including mental
health), and respiratory. Our founder, Eleanor McFadden, quite
literally wrote the book on the management of data in clinical
trials (available here). We have contributed to multiple
peer-reviewed medical and statistical journals. We’re passionate
about evolving the clinical research field and advancing patient
health.
With our biostatistical expertise we ensure the correct
statistical analysis methods are applied, resulting in accurate,
interpretable results. With our data management services, we
provide clean, accurate, complete, and reliable datasets for
analysis, no matter the size, type, or complexity of the clinical
trial. Quality assurance matters when running trials, and we can
provide regulatory compliance consultancy, a quality management
system, and technical writing, to ensure all stakeholders have the
utmost confidence in the results. We provide seamless
collaboration, which is the secret to success in clinical
trials.
Through our partners Alchemy Medical Writing, and iDE8, we offer
additional services, including regulatory writing, medical
communications, and medical device consultancy, including strategic
technology licensing. We work closely with key international
oncology collaborators including Belgium’s Breast International
Group (BIG) and the Jules Bordet Institute (IJB), as well as the
Frontier Science Foundation (FSF), which provides innovative data
management and analysis for clinical trials.
A proudly independent, not-for-profit, organisation, FSS was
founded over twenty years ago in the Scottish Highlands. FSS has
built up a highly experienced team, the majority with a Masters
degree or higher, several of whom serve as volunteers on national
and international panels including trial steering committees,
funding review panels, human research ethics committees and
independent data monitoring committees.
Follow us on LinkedIn and visit our website for a wealth of case
studies.
Media Inquiries
Frontier Science Scotland
Dr. Darren Gibson, Executive
Directorb2b@frontier-science.co.uk
Scius Communications
Katja StoutTel: +44 7789 435
990katja@sciuscommunications.com
Daniel GoochTel: +44 7747 875
479daniel@sciuscommunications.com